Goldman Sachs Group Inc Silence Therapeutics PLC Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Goldman Sachs Group Inc holds 24,375 shares of SLN stock, worth $134,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,375
Previous 24,375 -0.0%
Holding current value
$134,550
Previous $68,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$2.82 - $7.41 $35,278 - $92,699
-12,510 Reduced 33.92%
24,375 $68,000
Q4 2024

Feb 11, 2025
BUY
$6.33 - $19.65 $39,581 - $122,871
6,253 Added 20.41%
36,885 $253,000
Q3 2024

Nov 14, 2024
BUY
$15.53 - $21.74 $223,259 - $312,534
14,376 Added 88.44%
30,632 $557,000
Q2 2024

Aug 13, 2024
SELL
$18.31 - $23.91 $100,393 - $131,098
-5,483 Reduced 25.22%
16,256 $308,000
Q1 2024

May 15, 2024
BUY
$17.39 - $26.25 $378,041 - $570,648
21,739 New
21,739 $469,000
Q3 2023

May 14, 2024
BUY
$5.07 - $10.74 $1.35 Million - $2.86 Million
266,667 New
266,667 $2.62 Million
Q3 2023

Nov 14, 2023
SELL
$5.07 - $10.74 $726,698 - $1.54 Million
-143,333 Reduced 34.96%
266,667 $2.62 Million
Q2 2023

May 14, 2024
SELL
$4.61 - $7.44 $1.15 Million - $1.86 Million
-250,000 Reduced 37.88%
410,000 $2.26 Million
Q2 2023

Aug 14, 2023
SELL
$4.61 - $7.44 $1.15 Million - $1.86 Million
-250,000 Reduced 37.88%
410,000 $2.26 Million
Q1 2023

May 14, 2024
SELL
$6.2 - $15.61 $1,171 - $2,950
-189 Reduced 0.03%
660,000 $4.09 Million
Q1 2023

May 11, 2023
SELL
$6.2 - $15.61 $1,171 - $2,950
-189 Reduced 0.03%
660,000 $4.09 Million
Q4 2022

May 14, 2024
BUY
$9.69 - $17.09 $1,831 - $3,230
189 Added 0.03%
660,189 $10.1 Million
Q4 2022

Feb 13, 2023
BUY
$9.69 - $17.09 $1,831 - $3,230
189 Added 0.03%
660,189 $10.1 Million
Q2 2022

May 14, 2024
BUY
$7.99 - $19.5 $5.27 Million - $12.9 Million
660,000 New
660,000 $7.82 Million
Q2 2022

Aug 15, 2022
SELL
$7.99 - $19.5 $2.44 Million - $5.96 Million
-305,815 Reduced 31.66%
660,000 $7.82 Million
Q1 2022

May 16, 2022
BUY
$16.5 - $23.89 $3.4 Million - $4.92 Million
205,815 Added 27.08%
965,815 $18.4 Million
Q4 2021

Feb 14, 2022
BUY
$20.61 - $25.71 $15.7 Million - $19.5 Million
760,000 New
760,000 $18.2 Million

Others Institutions Holding SLN

# of Institutions
61
Shares Held
22.7M
Call Options Held
1.3K
Put Options Held
2.6K
View Full List

About Silence Therapeutics plc

SLN Quotes by TradingView
  • Ticker SLN
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,888,400
  • Market Cap $198M
  • Description
  • Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...
More about SLN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email